Chemcon Speciality Chemicals
- Market cap
- ₹ 722 Cr.
- P/E
- 22.8x
- P/B
- 1.53x
- 52-week range
- 125 – 254.8
- ROE
- 5%
- ROCE
- 6%
- Dividend yield
- 3.2%
- Debt / equity
- 0.11
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Chemcon Speciality Chemicals Limited is an India-based company. The Company is engaged in manufacturing oilfield completion chemicals, pharmaceutical intermediaries and agro-chemicals. Its products include calcium bromide liquid, calcium bromide powder, sodium bromide solution, zinc bromide solution, hexamethyl disilazane (HMDS), Chloromethyl Isopropyl Carbonate (CMIC), Trimethyl Chlorosilane, Hexamethyl Disiloxane, Bromobenzene, and Ammonium Chloride. The Company manufactures specialized chemicals, such as HMDS and CMIC, which are predominantly used in the pharmaceuticals industry; Bromobenzene, which are used as agrochemical intermediates, and inorganic bromides, which are predominantly used as completion fluids in the oilfield industry. The Company serves various industries, such as Agro-chemical industries, oil and gas industries, and pharmaceutical industry.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Chemcon Speciality Chemicals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)22.8 against a typical 25.8: cheaper than most peers (1st = cheapest).52nd of 129
- Sales growth+21.9% against a typical +25.9% from a year earlier.65th of 112
- Profit growth+30.8% against a typical +42.4% from a year earlier.62nd of 102
- Share price, 3 months+29.5% against a typical −5.8%.16th of 118
- Size₹ 722 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).53rd of 126
Latest announcements
Exchange filings and their impact on the company.
- 24 Oct 2026Outcome of Board MeetingHigh impactPositiveStrong H1 with revenue up 23% and net profit up 52% YoY lifts 12-month earnings outlook sharply.
Chemcon Speciality Chemicals reported Q2 FY27 revenue of Rs 65.45 crore, up about 22% from last year, and net profit of Rs 7.52 crore, up about 31%. For the half year, revenue was Rs 131.94 crore and net profit Rs 18.48 crore, up 23% and 52% respectively, with better operating margins. The board also considered a dividend but decided not to declare one at this meeting.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Moderate safety, with caution
Rated BBB+ by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil BBB+ | Stable | 6 Jul 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Jul 2026 | Reaffirmed | Crisil BBB+ | — | CRISIL | ₹ 53 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 24 Oct 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2026, dividend and other business matters |
| 3 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 21 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 14 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 5 Aug 2025 | Financial Results/Other business matters | To consider and approve the Unaudited financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53 | 60 | 46 | 53 | 54 | 55 | 54 | 54 | 57 | 75 | 66 | 65 |
| Expenses | 47 | 55 | 38 | 44 | 43 | 49 | 46 | 47 | 51 | 67 | 51 | 54 |
| Operating Profit | 6 | 4 | 7 | 9 | 11 | 6 | 8 | 7 | 7 | 9 | 15 | 11 |
| OPM % | 12% | 7.4% | 15.6% | 16.2% | 20.8% | 10.6% | 14.5% | 12.8% | 11.6% | 11.8% | 23.2% | 16.9% |
| Other Income | 3 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Profit before tax | 6 | 4 | 7 | 9 | 12 | 5 | 8 | 8 | 7 | 9 | 15 | 10 |
| Tax % | 26.7% | 30.1% | 27.2% | 25.8% | 25.7% | 26.9% | 24.2% | 27.7% | 25% | 27.5% | 24.7% | 25.7% |
| Net Profit | 4 | 3 | 5 | 6 | 9 | 4 | 6 | 6 | 5 | 6 | 11 | 8 |
| EPS in Rs | 1.21 | 0.79 | 1.47 | 1.73 | 2.41 | 1.08 | 1.74 | 1.57 | 1.39 | 1.74 | 2.99 | 2.05 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 10%
- 5 Years
- 0%
- 3 Years
- −7%
- TTM
- 22%
- 10 Years
- 22%
- 5 Years
- −16%
- 3 Years
- −25%
- TTM
- 20%
- 10 Years
- —
- 5 Years
- −14%
- 3 Years
- −10%
- TTM
- —
- 10 Years
- 13%
- 5 Years
- 8%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Chemcon Speciality Chemicals | ₹ 227.99 | ₹ 722 Cr. | 22.8x | 1.5x | 5% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 53.4x | 11.1x | 0% | 0% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 114.5x | 32.1x | 0% | 0% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 0% | 0% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 38.5x | 5.2x | 0% | 0% |
| Coromandel International | ₹ 1,723.60 | ₹ 50,876 Cr. | 28x | 4.5x | 0% | 0% |
Management
- Kamalkumar Rajendra Aggarwal
- Executive Chairman of the Board, Managing Director
- Rajesh Chimanlal Gandhi
- Chief Financial Officer, Whole-time Director
- Shahilkumar Maheshbhai Kapatel
- Compliance Officer, Company Secretary
- Naresh Vijaykumar Goyal
- Joint Managing Director
- Navdeep Naresh Goyal
- Deputy Managing Director, Whole-Time Director
- Himanshu Prafulchandra Purohit
- Whole-time Director
- Jalpa Maneklal Chauhan
- Manger Marketing
- Ashish Babubhai Luhar
- Manager Production
Prices are delayed and for information only. Nothing on this page is investment advice.